Deep Knowledge Group is a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, media, philanthropy and more. Its subsidiaries include Deep Knowledge Ventures, Longevity.Capital, AI-Pharma.Capital, Longevity FinTech Company, Deep Knowledge Analytics, Aging Analytics Agency, NeuroTech Analytics, Biogerontology Research Foundation, Longevity Swiss Foundation, AI-Longevity Consortium at King’s College London, and Longevity International UK - Secretariat for the UK All Party Parliamentary Group for Longevity.
Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intelligence services to top-tier clients, including major investment funds and banks, family offices, insurance companies, government organizations, and big pharma companies among others.
Deep Knowledge Analytics is the leading DeepTech-focused analytical agency, producing advanced analytical reports on DeepTech and frontier-technology industries using sophisticated multi-dimensional analytical frameworks and algorithmic methods that combine hundreds of specially-designed and specifically-weighted metrics and parameters to deliver sophisticated market intelligence, pragmatic forecasting and tangible industry benchmarking.
Biogerontology Research Foundation is the UK’s charity focused on Longevity and on expediting the coming paradigm shift from disease treatment to personalized precision prevention. It was the main initial donor that provided financial and organisational support to Longevity International UK for the purpose of establishing the APPG for Longevity. It was also actively involved in the successful initiative of adding a new extension code for “ageing-related diseases” accepted in 2018 by the World Health Organization during the last revisions of its International Classification of Diseases framework.
Ageing Research at King’s (ARK) is a cross-faculty multidisciplinary consortium of investigators which brings together scholarship and research in ageing in several complementary areas. ARK represents King’s world class excellence for research on the biology of ageing, from the basic mechanisms in biogerontology to clinical translation and the social impact of ageing.The primary purpose of ARK is to enhance multidisciplinary research collaborations within King’s to better understand the mechanisms of ageing and improving health-span. As ageing consists of complex systems at the level of biology, psychology and society, in order to understand the processes of ageing and the nature of old age itself, it is important to bring together learning and research from a number of key disciplines. ARK is uniquely positioned to address the challenges of an ageing world, and to provide answers at multiple levels, from cellular mechanisms to social sciences.
Innovation Eye Limited is a new company jointly founded in March 2019 by Big Innovation Centre Limited and Deep Knowledge Analytics Ltd. to provide sophisticated market analytics, industry intelligence, comparative industry classification frameworks and benchmark case studies, developing advanced tools for analysis and visualization of technology and innovation ecosystems through reports, custom-made consultancy products and services, and dynamic interactive online IT-platforms. The aim is to optimize the strategic agendas of international corporations and technocratic governments seeking to implement, stabilise and optimise their global positions in advanced technology-driven industries. An aim is in particular to support the implementation of the digital economy across the world, and support developing nations to leapfrog development.
The All Party Parliamentary Group (APPG) for Longevity was set up in March 2019 to address the scientific, technological and socio-economic issues relating to our ageing demographic and promote living younger, healthier and longer lives. The APPG is aiming to produce, with partners and experts, a draft National Strategy by end 2019 setting out what the United Kingdom needs to do to meet the goal set by Government of five more years of healthy life expectancy by 2035 (HLE + 5) and at the same time to close the large social gap in healthy life expectancy. Through an ambitious action plan in 2020, the APPG aims to turn the ‘problem’ of ageing into one of the most promising opportunities of the 21st century – and secure Britain’s place as a global leader in longevity by providing access to the ‘longevity dividend’ to everyone equitably in society.
Longevity.International is an online interactive database of longevity scientists, companies, and investors. This platform allows different stakeholders in the longevity industry to connect, network, research and analyze. On the next stage this platform will also employ cutting-edge data visualization software and a networking section where various stakeholders within the longevity industry can connect and collaborate, where longevity companies are matched with the right investors, and where scientists can make contributions.
Funding Nav offers a holistic approach to fundraising for SME's. They are not accountants but a growing international team of experienced entrepreneurs with multi-industry track records. Funding Nav helps clients compete on even terms both for funding and for marketing and nowadays the two are often synonymous.